Immunological failure in an HIV élite controller: possible role of indirect markers of inflammation and benefit of antiretroviral therapy

AIDS. 2020 Mar 15;34(4):646-647. doi: 10.1097/QAD.0000000000002459.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antiretroviral Therapy, Highly Active
  • CD4 Lymphocyte Count
  • CD4-CD8 Ratio
  • HIV Infections / drug therapy
  • HIV Infections / immunology*
  • HIV Long-Term Survivors*
  • Humans
  • Inflammation / immunology
  • Male
  • Viral Load